Skip to content
AnalystLens

James Hardie Industries Annual Report, Year Ended Mar 31, 2003

Filing Date
Filed July 2, 2003
Period End
March 31, 2003
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. FY2025 annual report10-K · May ’25May ’25

Summary

Summary of the 20-F filed July 2, 2003. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries N.V.

(filed as Hardie James Industries) reported fiscal 2003 (year ended March 31, 2003) total net sales of $803.7 milliona, up from $606.9 million, with USA Fiber Cement contributing $599.7 million and Asia Pacific Fiber Cement $194.4 million. Operating profit rose to $131.6 million from $48.3 million, and income from continuing operations was $85.4 million versus $28.3 million. Net income was $170.5 million, or $0.37 per diluted share, including $85.1 million from discontinued operations, primarily the April 2002 sale of the Gypsum business for $345.0 million in cash and the March 2003 sale of the Las Vegas gypsum mine.

The company describes itself as the largest manufacturer of fiber cement products in the United States, Australia, New Zealand and the Philippines. Its U.S. fiber cement volume rose to 1,273.6 million square feet from 988.5 million, and the average U.S. selling price increased to $471b per thousand square feet from $450. Long-term debt fell to $165.0 million from $325.0 million, and shareholders' equity rose to $434.7 million from $370.7 million.

Cash flow from operations was $64.8 millionc, down from $76.6 million, and capital expenditures were $90.2 million. The filing also highlights risks investors should weigh: exposure to residential construction cycles, a Dutch finance subsidiary tax regime that the EU has ordered ended by December 31, 2010, and continuing indemnification obligations tied to asbestos claims involving former subsidiaries. The company transferred control of ABN 60 to the ABN 60 Foundation on March 31, 2003, and states that it does not believe it will have liability for the former subsidiaries' asbestos obligations.

Key Highlights

  1. Net sales rose to $803.7 million in fiscal 2003 from $606.9 million, with USA Fiber Cement at $599.7 million.
  2. Operating profit increased to $131.6 million from $48.3 million; income from continuing operations was $85.4 million versus $28.3 million.
  3. Net income of $170.5 million ($0.37 per diluted share) included $85.1 million from discontinued operations, mainly the Gypsum sale.
  4. Gypsum business sold to BPB U.S. Holdings, Inc. for $345.0 million cash, with an $81.4 million pre-tax gain; Las Vegas gypsum mine sold in March 2003 for a $49.2 million pre-tax gain.
  5. Long-term debt reduced to $165.0 million from $325.0 million after prepaying $60.0 million of notes, incurring a $9.9 million make-whole charge.
  6. USA Fiber Cement volume rose to 1,273.6 million square feet from 988.5 million, and the average selling price increased to $471 per thousand square feet from $450.
  7. Shareholders' equity increased to $434.7 million from $370.7 million, and cash and cash equivalents were $55.1 million at March 31, 2003.

Frequently Asked Questions

  1. What drove the increase in operating profit?

    The filing attributes the increase mainly to strong sales volume growth and higher average selling prices in USA Fiber Cement, along with improved manufacturing efficiencies and lower raw material costs in Asia Pacific. The prior year also included $28.1 million of restructuring and other operating expenses, most of which did not recur.

  2. How did the Gypsum divestiture affect reported results?

    Gypsum operations were reported as discontinued operations. The sale closed April 25, 2002, producing net proceeds of $334.4 million after selling costs and a pre-tax gain of $81.4 million, with $26.1 million of income tax expense.

  3. What asbestos-related exposure does the company disclose?

    Former subsidiaries that manufactured asbestos-containing products were transferred to the Medical Research and Compensation Foundation and, on March 31, 2003, ABN 60 was transferred to the ABN 60 Foundation. The company states it does not believe it will have liability for these entities' asbestos claims, though it has agreed to indemnify the ABN 60 Foundation for non-asbestos claims against ABN 60.

  4. What tax risks does the filing identify?

    The Dutch finance subsidiary benefits from the Netherlands International Group Finance Company regime, which the European Commission has said must end for the company by December 31, 2010. The filing also notes that proposed U.S. tax law changes could increase the company's effective tax rate, and that the company's U.S. treaty benefits depend on eligibility conditions.